Pharmaceuticals : Shots - Health News Pharmaceuticals

Multiple sclerosis pill Tecfidera is on the top 10 list of most costly specialty drugs, as measured by overall spending, for California's health benefit system for public workers and retirees. John/Flickr hide caption

toggle caption
John/Flickr

Martin Shkreli was CEO of Turing Pharmaceuticals when the company boosted the price of a drug by 5,000 percent. He has since resigned. Paul Taggart/Bloomberg via Getty Images hide caption

toggle caption
Paul Taggart/Bloomberg via Getty Images

A 12-week regimen of Harvoni is 90 percent effective in curing an infection with hepatitis C, doctors say. It also costs about $95,000. Baltimore Sun/TNS via Getty Images hide caption

toggle caption
Baltimore Sun/TNS via Getty Images

States Deny Pricey Hepatitis C Drugs To Most Medicaid Patients

  • Download
  • <iframe src="https://www.npr.org/player/embed/460086615/461206268" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A recent analysis by the Kaiser Family Foundation finds that Medicare recipients taking Revlimid for cancer could end up paying, on average, $11,538 out of pocket for the drug in 2016, even if the medicine is covered by their Medicare Part D plan. Carmine Galasso/MCT/Landov hide caption

toggle caption
Carmine Galasso/MCT/Landov

Breast cancer drug Herceptin is one of the medicines that are typically covered by insurers but often at a high out-of-pocket cost for patients. Jeff J Mitchell/Getty Images hide caption

toggle caption
Jeff J Mitchell/Getty Images
Diane Bigda/Getty Images/Illustration Works

Menopause: A Gold Mine For Marketers, Fewer Payoffs For Women

  • Download
  • <iframe src="https://www.npr.org/player/embed/455039878/455367763" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Maryland pharmacist Narender Dhallan often has to decide whether to fill a prescription and lose money or send a customer to another store. Cindy Carpien for NPR hide caption

toggle caption
Cindy Carpien for NPR

How Generic Drugs Can Cost Small Pharmacies Big Bucks

  • Download
  • <iframe src="https://www.npr.org/player/embed/450600567/450937911" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Sen. Charles Grassley, R-Iowa, and a Democratic colleague have introduced a bill that would require drugmakers and medical device companies to disclose payments made to physician assistants and nurses who can prescribe their products. Brendan Smialowski/AFP/Getty Images hide caption

toggle caption
Brendan Smialowski/AFP/Getty Images